Holen Sie sich die Stockscreener-App
2.965
2.15%
-0.065
Schlusskurs vom Vortag:
$3.03
Offen:
$2.94
24-Stunden-Volumen:
4,849
Relative Volume:
1.44
Marktkapitalisierung:
$81.86M
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
+6.66%
1M Leistung:
+0.00%
6M Leistung:
+0.00%
1J Leistung:
+0.00%
1-Tages-Spanne:
$2.8568
$2.9603
1-Wochen-Bereich:
$2.68
$3.07
52-Wochen-Spanne:
$2.68
$3.07
Insight Molecular Diagnostics Inc Stock (IMDX) Company Profile
Firmenname
Insight Molecular Diagnostics Inc
Sektor
Branche
Telefon
949-409-7600
Adresse
15 CUSHING, IRVINE
Vergleichen Sie IMDX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
IMDX
Insight Molecular Diagnostics Inc
|
2.8622 | 81.22M | 0 | 0 | 0 | 0.00 |
|
TMO
Thermo Fisher Scientific Inc
|
424.04 | 160.56B | 42.90B | 6.52B | 6.72B | 17.05 |
|
DHR
Danaher Corp
|
193.93 | 141.52B | 23.82B | 3.77B | 4.90B | 5.15 |
|
IDXX
Idexx Laboratories Inc
|
528.82 | 42.74B | 3.93B | 894.97M | 837.70M | 10.82 |
|
A
Agilent Technologies Inc
|
115.84 | 34.11B | 6.63B | 1.17B | 1.19B | 4.05 |
|
IQV
Iqvia Holdings Inc
|
183.40 | 27.70B | 15.50B | 1.33B | 2.16B | 7.34 |
Insight Molecular Diagnostics Inc Stock (IMDX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-03-28 | Eingeleitet | Lake Street | Buy |
| 2022-05-24 | Herabstufung | Stephens | Overweight → Equal-Weight |
| 2022-03-14 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2022-01-07 | Eingeleitet | Stephens | Overweight |
| 2022-01-06 | Fortgesetzt | Piper Sandler | Overweight |
| 2021-03-17 | Fortgesetzt | Needham | Buy |
| 2021-01-07 | Hochstufung | The Benchmark Company | Speculative Buy → Buy |
| 2020-12-16 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2020-11-30 | Eingeleitet | BTIG Research | Buy |
| 2020-11-10 | Eingeleitet | KeyBanc Capital Markets | Overweight |
| 2020-07-30 | Bestätigt | The Benchmark Company | Speculative Buy |
| 2020-07-01 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2020-06-30 | Herabstufung | Chardan Capital Markets | Buy → Neutral |
| 2020-06-02 | Eingeleitet | Needham | Buy |
| 2019-02-13 | Eingeleitet | Piper Jaffray | Overweight |
| 2019-01-29 | Hochstufung | Janney | Neutral → Buy |
| 2018-12-19 | Fortgesetzt | Lake Street | Buy |
Alle ansehen
Insight Molecular Diagnostics Inc Aktie (IMDX) Neueste Nachrichten
Insight Molecular Diagnostics Insiders Placed Bullish Bets Worth US$2.82m - Yahoo Finance
U.S. In Vitro Diagnostics (IVD) Market and Competition - GlobeNewswire
U.S. In Vitro Diagnostics (IVD) Market and Competition Insights 2025-2034Next-Gen Genomic Tools and Decentralized Testing to Transform U.S. Diagnostics Landscape - yahoo.co
Clinical Laboratory Services Market Expanding with Diagnostic Testing Growth and Automation Advancements - newstrail.com
Sepsis Diagnostics Market: Global Industry Overview, Trends, Challenges, and Regional Insights - PharmiWeb.com
Proteinase K Market Grows Amid Rising Demand for Molecular Research and Diagnostics - newstrail.com
Companion Diagnostic Technologies Market Watch: Strategic Forecasts Amid Rising Economic Volatility - newstrail.com
IVD Contract Manufacturing Services Market Watch: Strategic Forecasts Amid Rising Economic Volatility - newstrail.com
Molecular Diagnostics Market Future Business Opportunities 2025-2032 | USD 27.8 billion by 2032, CAGR of 9.1% - newstrail.com
3 Medical Info Systems Stocks to Buy Amid AI Boom and Tariff Risk - Yahoo Finance
Molecular Diagnostics Market Booming as Precision Medicine, - openPR.com
Liver Cancer Diagnostics Market Analysis 2025–2035 | Trends, Technologies & Regional Insights - PharmiWeb.com
Molecular Diagnostics Reagent Market Driven by Rising Infectious Diseases and Genetic Testing - openPR.com
PCR Molecular Diagnostics Market Global Forecast 2025–2032: Sector-Wise Insights - newstrail.com
Oncocyte Relocates HQ from Irvine to Nashville - Orange County Business Journal
Insight Molecular Diagnostics Approves Key Proposals at Annual Meeting - TipRanks
Seegene Launches STAgora™, a New Platform for Infectious Disease Analytics - PR Newswire
Insight Molecular Diagnostics Inc.(NasdaqCM:IMDX) dropped from Russell 3000E Growth Index - MarketScreener
Revolutionizing Healthcare: Molecular Diagnostics Market Set - openPR.com
What's Driving the Future of the Molecular Cytogenetics Market? - openPR.com
Oncology Molecular Diagnostics Market in Flux: Recession Signals, Tariff Pressures & Strategic Forecasts - newstrail.com
Early cancer detection company opening U.S. headquarters in Franklin - Nashville Post
Insight Molecular Diagnostics shares fall 2.46% in after-hours trading due to high price-to-sales ratio and sector fund rotation. - AInvest
Why Did Insight Molecular Plunge 12.28%? - AInvest
IMDXINSIGHT MOLECULAR DIAGNOSTICS INC Latest Stock News & Market Updates - Stock Titan
OncoCyte Rebrands to Insight Molecular Diagnostics - TipRanks
Oncocyte Changes Name to Insight Molecular Diagnostics, Relocates HQ to Nashville - MarketScreener
Point-of-Care Molecular Diagnostics Market Future Business - openPR.com
Digital PCR and Real-Time PCR Market Size Worth USD 17.54 billion by 2031 at 9.1% CAGR | The Insight Partners - GlobeNewswire
In Vitro Diagnostics Market Share worth $150.13 billion, Globally by 2030Exclusive Report by The Research Insights - PR Newswire
Precision Medicine: Genomics, Genetics & Molecular Diagnostics Virtual Event Series 2025 - Labroots
QIAGEN enhances leading clinical genomics portfolio with acquisition of Genoox AI-powered software - Business Wire
Global Molecular Diagnostics Market to Expand at a CAGR of - GlobeNewswire
Point of Care Diagnostics Market Size to Reach $82.95 Bn by 2028 Globally, at 12.7% CAGR: The Insight Partners - GlobeNewswire
Microbial Identification Methods Market Forecasted to Grow - GlobeNewswire
Veterinary Diagnostics Market Set to Reach USD 7.27 Billion by 2030, Driven by Zoonotic Diseases and Technological AdvancementsThe Insight Partners - Yahoo Finance
Cardio Diagnostics Holdings, Inc. to Showcase Enhanced PrecisionCHD™, Actionable Clinical Intelligence™ and New Clinical Advancements at the American College of Cardiology’s 74th Annual Scientific Session - Business Wire
[Latest] Global Medical Imaging Reagents Market Size/Share Worth USD 19.31 Billion by 2034 at a 5.1% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value) - GlobeNewswire
Global Endometriosis Treatment Market Set for Robust Growth, Projected to Reach USD 6,297.2 million by 2035 amid Advancements in Diagnostics and Emerging Targeted Therapies | FMI - GlobeNewswire
[Latest] Global Synthetic Biology Market Size/Share Worth USD 150.93 Billion by 2034 at a 25% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value) - GlobeNewswire
Global Antimicrobial Susceptibility Testing Market to Reach - GlobeNewswire
Nuclear Medicine Market to hit USD 54.7 billion by 2032, says Global Market Insights Inc. - GlobeNewswire
In-Vitro Diagnostics Packaging Market Size, Share, Report, 2034 - Global Market Insights
Untargeted metabolomics profiling of gestational diabetes mellitus: insights into early diagnosis and metabolic pathway alterations - Frontiers
Clinical Reference Laboratory Market to hit USD 78 billion by 2032, says Global Market Insights Inc. - GlobeNewswire
Hereditary Testing Market Size, Growth Outlook 2025 – 2034 - Global Market Insights
Poultry Diagnostics Market to hit USD 1.7 billion by 2032, says Global Market Insights Inc. - GlobeNewswire
Lyme Disease Testing Market Size & Share Report, 2034 - Global Market Insights
Proteinase K Market to hit USD 2.5 billion by 2032, says Global Market Insights Inc. - GlobeNewswire
Cancer Diagnostics Market Size, Share | Global Report [2032] - Fortune Business Insights
Influenza Diagnostics Market Growth, Insights, Opportunities and Emerging Technologies | Exactitude Consultancy - GlobeNewswire
Finanzdaten der Insight Molecular Diagnostics Inc-Aktie (IMDX)
Es liegen keine Finanzdaten für Insight Molecular Diagnostics Inc (IMDX) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
2.53%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):